Abstract
Several indole derivatives and analogues comprising a range of related structural classes were designed, synthesized and tested as ligands for the 5-HT4 receptor. Within each series, binding experiments showed compounds with good affinity demonstrating high percentage displacement values at 1 µM. The most potent of these (20) had a pKi of 8.54 demonstrating very good affinity. These indole analogues were combined with 55 ligands that were previously produced in our laboratory to explore the structure-activity relationships of these 5-HT4 ligands. A CoMFA (Comparative Molecular Field Analysis) analysis was used to extend an earlier simple pharmacophore to suggest two new molecular features beyond the primary amino binding site. The pharmacophore confirmed that a newly described tetrahydroquinoline analogue was able to match the basic requirements of the model and the pharmacology of this molecule is provided in more detail.
Keywords: 5-HT4 ligands, radioligand binding, CoMFA, pharmacophore, molecular modelling, tetrahydroquinoline, gastroesophageal reflux disease, irritable bowel syndrome, TopCount Microplate Scintillation Counter, cisapride, metoclopramide, NMR spectrometer, Micromass Platform II single quadrupole mass spectrometer, electrospray, column chromatography
Medicinal Chemistry
Title: Synthesis, Testing and Structure-Activity Studies on a Library of 5-HT4 Ligands
Volume: 6 Issue: 6
Author(s): Amir Hanna-Elias, David T. Manallack, Alla Levit, William Nguyen, Fadi Ayad, Glen Perera, Marina Shapiro, Helen R. Irving, Ian M. Coupar and Magdy N. Iskander
Affiliation:
Keywords: 5-HT4 ligands, radioligand binding, CoMFA, pharmacophore, molecular modelling, tetrahydroquinoline, gastroesophageal reflux disease, irritable bowel syndrome, TopCount Microplate Scintillation Counter, cisapride, metoclopramide, NMR spectrometer, Micromass Platform II single quadrupole mass spectrometer, electrospray, column chromatography
Abstract: Several indole derivatives and analogues comprising a range of related structural classes were designed, synthesized and tested as ligands for the 5-HT4 receptor. Within each series, binding experiments showed compounds with good affinity demonstrating high percentage displacement values at 1 µM. The most potent of these (20) had a pKi of 8.54 demonstrating very good affinity. These indole analogues were combined with 55 ligands that were previously produced in our laboratory to explore the structure-activity relationships of these 5-HT4 ligands. A CoMFA (Comparative Molecular Field Analysis) analysis was used to extend an earlier simple pharmacophore to suggest two new molecular features beyond the primary amino binding site. The pharmacophore confirmed that a newly described tetrahydroquinoline analogue was able to match the basic requirements of the model and the pharmacology of this molecule is provided in more detail.
Export Options
About this article
Cite this article as:
Hanna-Elias Amir, T. Manallack David, Levit Alla, Nguyen William, Ayad Fadi, Perera Glen, Shapiro Marina, R. Irving Helen, M. Coupar Ian and N. Iskander Magdy, Synthesis, Testing and Structure-Activity Studies on a Library of 5-HT4 Ligands, Medicinal Chemistry 2010; 6 (6) . https://dx.doi.org/10.2174/157340610793563965
DOI https://dx.doi.org/10.2174/157340610793563965 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Systemic Lupus Erythematosus-Related Interstitial Lung Disease
Current Rheumatology Reviews Sodium Channel Inhibitor Drug Discovery Using Automated High Throughput Electrophysiology Platforms
Combinatorial Chemistry & High Throughput Screening Critical Steps in Tissue Processing in Histopathology
Recent Patents on DNA & Gene Sequences Enteral and Parenteral Nutrition Therapy for Crohns Disease
Current Pharmaceutical Design Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1
Current Alzheimer Research The Impact of Fc Receptors on the Development of Autoimmune Diseases
Current Pharmaceutical Design Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Multiscale Modelling of Relationships between Protein Classes and Drug Behavior Across all Diseases Using the CANDO Platform
Mini-Reviews in Medicinal Chemistry P2Y Purinoceptors as Potential Emerging Therapeutical Target in Vascular Disease
Current Pharmaceutical Design Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies
Current Drug Abuse Reviews Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
Current Drug Metabolism GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Current Pharmaceutical Design <i>In Silico</i> Docking Studies of Vascular Endothelial Growth Factor-A (VEGFA): Possible Implications in Chronic Myeloid Leukemia (CML) Therapy
Current Proteomics Pantothenate Kinase-Associated Neurodegeneration
Current Drug Targets The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge
Current Signal Transduction Therapy Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery